22nd Mar 2011 16:20
22 March 2011
Completion of acquisition and placing and total voting rights
Cello Group plc, ("Cello" or the "Company"), the insight and strategic marketing group, is pleased to announce that following the admission to trading on AIM of 11,137,382 new Cello ordinary shares of 10p each ("Ordinary Shares") on 21 March, it has successfully completed the acquisition of Medergy HealthGroup Inc. and the placing to raise £2.8m from new and existing institutional shareholders and certain directors of the Company.
Following admission, Cello's issued share capital consists of 72,782,036 Ordinary Shares. The Company holds 237,000 Ordinary Shares in treasury. Therefore, the Company has 72,545,036 Ordinary Shares with voting rights at the date of this announcement.
The above figure (72,545,036 Ordinary Shares) may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FSA's Disclosure and Transparency Rules.
Enquiries
Cello Group plc | |
Mark Scott, Chief Executive | 020 7812 8460 |
Mark Bentley, Group Finance Director | |
Altium | |
Ben Thorne | 020 7848 4040 |
Paul Chamberlain | |
Nick Burt | |
College Hill | 020 7457 2020 |
Kay Larsen | |
Rozi Morris |
Related Shares:
CLL.L